IVA vs DNA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 03, 2026

IVA

59.2
AI Score
VS
IVA Wins

DNA

35.0
AI Score

Investment Advisor Scores

IVA

59score
Recommendation
HOLD

DNA

35score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric IVA DNA Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -76.7% -48.5% DNA
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 59.2/100 35.0/100 IVA
Profit Margin 0.0% -219.6% IVA
Beta 1.00 1.00 Tie
AI Recommendation HOLD EXTENDED Tie

Relative Price Performance (Last 90 Days)

IVA 1M: -26.7% · 3M: -8.7% DNA 1M: +75.7% · 3M: +22.2%

Current Technical Phase

IVA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -3.5%), weak momentum, RSI 41

RSI (14): 41.2 · Price: $3.56

DNA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 75

RSI (14): 74.6 · Price: $12.35

Fundamentals Snapshot

Metric IVA DNA
Market Cap — —
Forward P/E -4.7 -4.3
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.8% -0.5%
Gross Margin 0.8% 0.7%
Operating Margin -53.4% -2.8%
EPS -0.57 -5.19
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, IVA is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.